Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Schizophr Res. 2010 Feb 25;118(1-3):264–270. doi: 10.1016/j.schres.2010.01.026

Table 2. 6-Month Outcomes.

HARP (n=41) Usual Care
(n=39)
p value p value for
group*time
interaction
Patient Activation (0-100 ) 0.03
 Baseline 48.3 +/−11.5 47.6+/−12.3 0.96
 6-months 52.0+/−10.1 44.9+/−9.6 0.01
One or More Primary Care
Visit
 Baseline 24 (58.5%) 23 (61.1%) 0.60 0.046
 6-months 26 (68.4%) 14 (51.9%) 0.18
Moderate or Vigorous
Physical Activity
(minutes/week)
 Baseline 150+/−236 154+/−194 0.88 0.40
 6-months 191+/−278 152+/249 0.14
Medication Adherence
(lower score indicates
better adherence)
 Baseline 1.5+/−1.2 1.5+/−1.4 0.78 0.22
 6-months 1.3+/−1.3 1.6+/−1.4 0.25
Physical Health Related
Quality of Life (higher
score indicates better
health)
 Baseline 36.9+/−10.3 37.0+/−12.5 0.98 0.41
 6-months 42.9+/−14.2 40.0+/−13.7 0.27
Mental Health Related
Quality of Life (higher
score indicates better
health)
 baseline 33.3+/−9.13 33.9+/−9.3 0.80 0.96
 6-months 36.8+/−10.0 37.0+/−11.8 0.95